technetium tc 99m sestamibi has been researched along with (dtpa-phe(1))-octreotide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitakata, Y; Kuyama, J; Sakata, S; Uchida, Y; Uno, K | 1 |
| Borson-Chazot, F; Houzard, C; Sassolas, G; Sigartau, C | 1 |
| D'Eredità , G; Rubini, G | 1 |
1 review(s) available for technetium tc 99m sestamibi and (dtpa-phe(1))-octreotide
| Article | Year |
|---|---|
[Tumor imaging in nuclear medicine].
Topics: Citric Acid; Gallium Radioisotopes; Gamma Cameras; Humans; Indium Radioisotopes; Neoplasms; Octreotide; Pentetic Acid; Technetium Tc 99m Sestamibi; Thallium; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1996 |
2 other study(ies) available for technetium tc 99m sestamibi and (dtpa-phe(1))-octreotide
| Article | Year |
|---|---|
[Value of scintigraphic explorations by radiomarkers others than iodine radioisotope in differentiated thyroid cancer].
Topics: Adenocarcinoma; Carcinoma, Papillary; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium; Thyroid Neoplasms | 1997 |
Tc-99m sestamibi and In-111 DTPA octreotide uptake in breast carcinoma with neurendocrine differentiation.
Topics: Aged; Breast Neoplasms; Carcinoma; Carcinoma, Neuroendocrine; Diagnosis, Differential; Female; Humans; Indium Radioisotopes; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Terbium | 2000 |